Navigation Links
Sunflowers Could Hold the Key to New Class of AIDS Drugs

Scientists at the University of Bonn in Germany have come up with what could be a potential AIDS drug. They have found that a substance present in sunflowers prevents // the AIDS virus from replicating in cell cultures. It is not yet known if this would also apply to the actual disease.

The substance called as 'DCQA' has been the sole hope of producing a new class of AIDS drugs. But this is available in very minute quantities and naturally is pretty costly. The researchers from Bonn worked in collaboration with the Caesar research centre to make this substance available at a fraction of the earlier costs. The attempt to find the substance in sunflowers started with a mould called sclerotinia sclerotiorum. It was found that some varieties of sunflower were resistant to a disease called "white stem rot' that destroys the crops. Agricultural engineer Claudio Cerboncini proceeded to isolate the substance that confers protection on the sunflowers that are resistant to this fungal disease. The substance was dicaffeoyl quinic acid, or DCQA. "Dicaffeoyl quinic acid can prevent the HI virus from reproducing, at least in cell cultures," said Claudio Cerboncini.

"It is one of the few substances known today which inhibit viral integrase - this is an enzyme which is essential if the pathogen is to reproduce." Preliminary clinical tests have now borne out the hope that DCQA could herald in a new class of AIDS drugs. Dr. Esther Vogt of the Immunological Out-Patient Service of Bonn University Clinic, said, "We need these substances to expand our arsenal of effective weapons against the disease. It remains to be seen, however, whether they will prove to be as effective in clinical practice as they seem to be at present." The University of Bonn researchers have teamed up with Jülich Research Centre to see if they can manufacture this substance on a large scale.

Dr. Ralf Theisen
University of Bonn


Related medicine news :

1. Oleic-acid-rich Sunflowers Give Trans-fat Alternative - Study
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Nasal Spray Could Take Drugs Directly to Brain
5. Oxygen Usage During Exercise Could Indicate Heart Problems
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. Anger Could Be Linked To Weight Gain
8. A Seizure Late In Life Could be A Stroke Warning
9. New Findings Could Reduce The Extent Of Spinal Cord Injuries
10. Could There Be A Link Between Famine and Breast Cancer ?
11. Bone Marrow Cells Could Yield A New Lease of Life
Post Your Comments:

(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted general ... of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many ... the doctor uses other traditional cutting tools, such as the scalpel and high-speed drill, ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... ... sizes, has launched their Black Friday sale a week early, offering 40% off ... to transform the intimate apparel industry through both mobile fit technology and the ...
(Date:11/24/2015)... ... 24, 2015 , ... The hospitals and health systems on ... orthopedic care. They have received recognition for excellence from various reputable organizations in ... Becker's Hospital Review selected hospitals for inclusion based on national rankings and awards ...
(Date:11/24/2015)... Berkeley, California (PRWEB) , ... November 24, 2015 ... ... Brillouin Energy's LENR HHT Bolier Reactor System. Brillouin is the developer of renewable ... on controlled low energy nuclear reactions (“LENR”), announced today that its WET™ and ...
(Date:11/24/2015)... ... November 24, 2015 , ... The American Association of Poison ... poison centers through donations on Tuesday, Dec. 1, 2015. Since 2012, the Tuesday ... inspires people to collaborate in improving their local communities and help give back ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 ... global pharmaceutical company, and Rugen Therapeutics, a start-up ... treatments for unmet CNS disorders and funded by ... that they have entered into an exclusive collaboration ... therapies for Autism Spectrum Disorders (ASD) and Obsessive ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ ... "Company") (NYSE: MR ), a ... medical devices worldwide, today announced that ... general meeting of shareholders at the ... Grand Century, 193 Prince Edward West Road, ...
(Date:11/25/2015)... , November 25, 2015 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering.  ... the addition of the  "Global Drug ...  report to their offering.  --> ...
Breaking Medicine Technology: